Advice

following an abbreviated submission:

ciprofloxacin ear drops (Cetraxal®) are accepted for restricted use within NHS Scotland.

Indication under review: treatment of acute otitis externa in adults and children older than 1 year with an intact tympanic membrane, caused by ciprofloxacin susceptible microorganisms.

SMC restriction: when off-label or unlicensed ciprofloxacin formulations would otherwise be used.

Ciprofloxacin eye drops (used off-label) or unlicensed ciprofloxacin ear drops have been in use in NHS Scotland for this indication. Ciprofloxacin ear drops (Cetraxal®) provide a licensed alternative.

Download full details126KB (PDF)

Download

Medicine details

Medicine name:
ciprofloxacin hydrochloride (Cetraxal)
SMC ID:
1320/18
Indication:
Treatment of acute otitis externa in adults and children older than 1 year with an intact tympanic membrane, caused by ciprofloxacin susceptible microorganisms.
Pharmaceutical company
Aspire Pharma Ltd
BNF chapter
Ear, nose and oropharynx
Submission type
Abbreviated submission
Status
Restricted
Date advice published:
09 April 2018